NCT04449627

Brief Summary

Studies have shown that admission to hospital during a coronavirus epidemic is associated with increased levels of anxiety, depression and panic disorder. During the SARS-CoV-2 pandemic in North London the Royal Free Hospital admitted over 500 patients with Covid-19. As part of the standard of care, these patients are screened at 8 weeks post discharge for signs of anxiety and depression. The Feeling Good app is a NHS approved digital application which utilises applied relaxation, mindfulness based cognitive therapy and positive visualisation through audio tracks for the treatment of anxiety and depression. This is a naturalistic cohort study aimed to track the post illness psychological symptoms of those who have been admitted with Covid-19 to the Royal Free hospital up to 5-7 months after discharge. The study population is those who are exhibiting anxiety or depressive symptoms as measure by the PHQ-2 or TSQ questionnaires. All those with symptoms will be offered free access to a NHS approved app for anxiety and depression, and followed up for 3 months after recruitment to track changes to their symptoms.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2020

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

June 29, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

August 31, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2021

Completed
Last Updated

August 28, 2020

Status Verified

August 1, 2020

Enrollment Period

2 months

First QC Date

June 11, 2020

Last Update Submit

August 26, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Anxiety as measured by generalised anxiety disorder score (GAD-7) scale

    Generalised anxiety disorder score (GAD-7) scale. Score 0-21, with a higher score associated with greater anxiety symptoms. Scores of 5, 10, and 15 represent cut-points for mild, moderate, and severe anxiety, respectively. GAD-7 score at baseline will be controlled for.

    Day 14

Secondary Outcomes (3)

  • Depression as measured by the patient health questionnaire 9 (PHQ-9)

    14 days and week 12

  • Trauma as measured by Trauma screening questionnaire (TSQ)

    12 weeks

  • Anxiety as measured by generalised anxiety disorder score (GAD-7) scale

    Week 12

Other Outcomes (2)

  • Risk associated with distress

    Baseline analysis

  • Qualitative analysis

    Baseline

Study Arms (1)

Naturalistic cohort

Patients who were hospitalised between March and June from Covid19, who did not require treatment in intensive care, who at 8 weeks post discharge have symptoms of anxiety or depression. All patients are offered access to an audio based self help programme based on applied relaxation and mindfulness based cognitive therapy.

Other: Feeling Good Digital App

Interventions

Audio based tracks using Jacobson relaxation and mindfullness based cognitive therapy (MBCT) techniques including positive visualisation.

Naturalistic cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who were hospitalised with Covid19 who have psychological symptoms 8 weeks after discharge. That is a \>=6 on TSQ or \>= 3 on PHQ9.

You may qualify if:

  • Over the age of 18
  • Treated for Covid-19 at the Royal Free Hospital
  • Capacity to consent AND
  • At screening had a PHQ-2 score \>=3 (positive) OR
  • At screening had a TSQ score \>= 6 (positive)

You may not qualify if:

  • A current inpatient
  • Participant on alternative trial that excludes being in a secondary trial
  • Patient currently using alternative MBCT app tool
  • Patients under 18 years old
  • Background of psychotic illness
  • Patient declined
  • Patient unable to consent
  • Underlying cognitive impairment which may impede ability to comply with the intervention
  • Severe hearing impairment
  • Current delirium
  • Was an in-patient in intensive care during hospital stay
  • Unable to contact patient via telephone on 2 attempts Patient is not registered with a GP. Unable to understand English proficiently enough to engage with the audio tracks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anxiety DisordersStress Disorders, Post-TraumaticDepressive DisorderCOVID-19

Condition Hierarchy (Ancestors)

Mental DisordersStress Disorders, TraumaticTrauma and Stressor Related DisordersMood DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Research and Development Manager

    Sponsor GmbH

    STUDY CHAIR

Central Study Contacts

Joanna Dobbin, MScMBBS

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2020

First Posted

June 29, 2020

Study Start

August 31, 2020

Primary Completion

October 31, 2020

Study Completion

January 31, 2021

Last Updated

August 28, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share